Comparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week result

Shaohang Cai(Key Laboratory of Guangdong Province), Jie Peng(Guiyang Medical University), Yonghong Zhang(Soochow University), Tao Yu(Nanfang Hospital), Fangfang Lv(Sir Run Run Shaw Hospital), Ye-gui Jiang(Army Medical University)

Clinical and Experimental Medicine

July 11, 2015

10.1007/s10238-015-0373-2

Cited by 48

Related Papers

Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging

|European Radiology|2019|219

Suppression of ACADM-Mediated Fatty Acid Oxidation Promotes Hepatocellular Carcinoma via Aberrant CAV1/SREBP1 Signaling

|Cancer Research|2021|127

ACP risk grade: a simple mortality index for patients with confirmed or suspected severe acute respiratory syndrome coronavirus 2 disease (COVID-19) during the early stage of outbreak in Wuhan, China

|medRxiv|2020|112

<i>Retracted:</i><scp>HB</scp>x‐mediated decrease of <scp>AIM</scp>2 contributes to hepatocellular carcinoma metastasis

|Molecular Oncology|2017|92

Association Between Clinical Manifestations and Prognosis in Patients with COVID-19

|Clinical Therapeutics|2020|84